
    
      All patients will receive weekly topotecan.

      Topotecan 6mg/m2 IV weekly x 6 consecutive weeks followed by a 2 week break. Cycles are
      repeated every 8 weeks, for 3 cycles. Restaging studies will be performed every cycle (or 8
      weeks.)
    
  